Skip to content
DataLookout
Start free
Menu

BAARDNCT07810738

The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.

StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below.

  1. Start date pushed from Oct 1, 2026 to Nov 1, 2026
    • Site details revised at 1 of 3 sites
  2. Study sites: 1 to 3
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Remission from Depression as measured by Montgomery-Asberg Depression Rating Scale (MADRS) score ≤10
Timeframe: Week 10

Arms and interventions

BAARD-assignedExperimental

The BAARD predictive model will use individual participants' data to advise which of two treatments to select, aripiprazole or bupropion.

Randomly assignedActive comparator

The randomly assigned arm will randomly assign one of two treatments to select, aripiprazole or bupropion.

Drugs: Aripiprazole Augmentation, Bupropion Augmentation

Sites

3 sites in 2 countries

United States 2, Canada 1